Partnership for Safe Medicine Executive Director Safdar Testifies Before House Oversight & Government Reform Committee
April 18, 2025
April 18, 2025
WASHINGTON, April 18 -- The House Oversight and Government Reform Committee released the following written testimony by Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, from an April 9, 2025, hearing entitled "Restoring Trust in FDA: Rooting Out Illicit Products." FDA is the Food and Drug Administration.
* * *
Chairman Comer, Ranking Member Connolly, and distinguished members of the House Oversight and Government Reform Committee . . .
* * *
Chairman Comer, Ranking Member Connolly, and distinguished members of the House Oversight and Government Reform Committee . . .